Projected Income Statement: Vaxcyte, Inc.

Forecast Balance Sheet: Vaxcyte, Inc.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -1,181 -1,381 -1,911
Change - - - - - - -216.93% -238.38%
Announcement Date 5/22/20 3/29/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million
Estimates

Cash Flow Forecast: Vaxcyte, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 1.155 6.555 5.848 16.06 5 7 9
Change - 467.53% -10.79% 174.66% -68.87% 40% 28.57%
Free Cash Flow (FCF) 1 - -127.9 -66.37 -312.9 -509.5 -544.5 -516
Change - - -48.13% 371.39% 62.86% 6.87% -5.23%
Announcement Date 3/29/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Vaxcyte, Inc.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) - - - - - - - -3,133.56%
EBIT Margin (%) - - - - - - - -2,611.79%
EBT Margin (%) - - - - - - - -1,994.8%
Net margin (%) - - - - - - - -2,162.1%
FCF margin (%) - - - - - - - -2,064%
FCF / Net Income (%) - - 127.85% 29.7% 77.77% 103.97% 97.36% 95.46%

Profitability

        
ROA - - - - - - - -
ROE - -44.63% -17.71% -36.12% -36.67% -25.49% - -

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) - - - - - - - 36%
CAPEX / EBITDA (%) - -1.31% -6.43% -2.55% -3.46% -0.92% -1.16% -1.15%
CAPEX / FCF (%) - - -5.12% -8.81% -5.13% -0.98% -1.29% -1.74%

Items per share

        
Cash flow per share 1 - -1.578 -2.338 -2.63 -2.988 -3.355 -3.231 -
Change - - 48.14% 12.47% 13.62% 12.29% -3.69% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 - - - - - - - -
Change - - - - - - - -
EPS 1 -13.24 -3.02 -1.93 -3.44 -4.14 -4.068 -4.453 -4.425
Change - -77.2% -36.09% 78.24% 20.35% -1.73% 9.46% -0.64%
Nbr of stocks (in thousands) - 50,950 52,785 78,980 95,154 124,637 124,637 124,637
Announcement Date 5/22/20 3/29/21 2/28/22 2/27/23 2/27/24 - - -
1USD
Estimates
2024 *2025 *
P/E ratio -21.5x -19.6x
PBR - -
EV / Sales - -
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
87.42USD
Average target price
149.89USD
Spread / Average Target
+71.46%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PCVX Stock
  4. Financials Vaxcyte, Inc.